List of genetic disorders
The following is a list of genetic disorders and if known, type of mutation and for the chromosome involved. Although the parlance "disease-causing gene" is common, it is the occurrence of an abnormality in the parents that causes the impairment to develop within the child. There are over 6,000 known genetic disorders in humans.
Most common
- P – Point mutation, or any insertion/deletion entirely inside one gene
- D – Deletion of a gene or genes
- Dup - Duplication of a gene or genes
- C – Whole chromosome extra, missing, or both (see chromosome abnormality)
- T – Trinucleotide repeat disorders: gene is extended in length
Disorder | Chromosome | Mutation |
---|---|---|
Angelman syndrome | 15 b | DCP |
Canavan disease | 17p | |
Charcot–Marie–Tooth disease | 17p12[1] | Dup |
Color blindness | X | P |
Cri du chat syndrome | 5 | D |
Cystic fibrosis | 7q | P |
DiGeorge syndrome | 22q | D |
Down syndrome | 21 | C |
Duchenne muscular dystrophy | Xp | D |
Familial hypercholesterolemia | 19 | P |
Haemochromatosis type 1 | 6 | P |
Hemophilia | X | P |
Klinefelter syndrome | X | C |
Neurofibromatosis | 17q/22q/? | |
Phenylketonuria | 12q | P |
Polycystic kidney disease | 16 (PKD1) or 4 (PKD2) | P |
Prader–Willi syndrome | 15 | DCP |
Scheuermann's disease | 1q21-q22 or 7q22 | |
Sickle cell disease | 11p | P |
Spinal muscular atrophy | 5q | DP |
Tay–Sachs disease | 15 | P |
Turner syndrome | X | C |
Full genetic disorders list
Disorder | Chromosome or gene | Type | Reference | Prevalence | |
---|---|---|---|---|---|
1p36 deletion syndrome | 1 | D | 1:7,500 | ||
1q21.1 deletion syndrome | 1q21.1 | D | |||
2q37 deletion syndrome | 2q37 | D | |||
5q deletion syndrome | 5q | D | |||
5,10-methenyltetrahydrofolate synthetase deficiency | MTHFS | [2] | |||
17q12 microdeletion syndrome | 17q12 | [3][4] | 1:14,000-62,500 | ||
17q12 microduplication syndrome | 17q12 | [5] | |||
18p deletion syndrome | 18p | D | 1:50,000 | ||
21-hydroxylase deficiency | 6p21.3 | recessive | 1:15,000 | ||
Alpha 1-antitrypsin deficiency | 14q32 | co-dominant, | 1:2,500-5,000 | ||
AAA syndrome (achalasia–addisonianism–alacrima syndrome) | AAAS | recessive | [6] | 1:1,000,000 | |
Aarskog–Scott syndrome | FGD1 | X-linked recessive | 1:25,000 | ||
ABCD syndrome | EDNRB | recessive | 1:18,000-20,000 | ||
Absence deformity of leg-cataract syndrome | |||||
Aceruloplasminemia | CP (3p26.3) | recessive | 1:2,000,000 | ||
Acheiropodia | LMBR1 | recessive | |||
Achondrogenesis type II | COL2A1 (12q13.11) | dominant | 1:40,000-60,000 | ||
achondroplasia | FGFR3 (4p16.3) | dominant | 1:27,500 | ||
Acute intermittent porphyria | HMBS | dominant and recessive forms | 1:500-50,000 | ||
Adenylosuccinate lyase deficiency | ADSL | recessive | |||
Adrenoleukodystrophy | ABCD1 (X) | recessive | 1:17,000 | ||
Alagille syndrome | JAG1, NOTCH2 | dominant | [7] | 1:30,000-50,000 | |
ADULT syndrome | TP63 | dominant | |||
Aicardi–Goutières syndrome | TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, IFIH1 | 1:19,500,000 | |||
Albinism | 1:18,000-20,000 | ||||
Alexander disease | GFAP | 1:15,600,000 | |||
Alfi's syndrome | 9p | monosomy | 1:50,000 | ||
alkaptonuria | HGD | 1:250,000-1,000,000 | |||
Alport syndrome | 10q26.13 COL4A3, COL4A4, and COL4A5 | 1:5,000-10,000 | |||
Alternating hemiplegia of childhood | ATP1A3 | 1:1,000,000 | |||
Aortic arch anomaly - peculiar facies - intellectual disability | dominant | ||||
Amish lethal microcephaly | SLC25A19 | recessive | |||
Amyotrophic lateral sclerosis – Frontotemporal dementia | C9orf72, SOD1, FUS, TARDBP, CHCHD10, MAPT | 1:100,000 | |||
Angel-shaped phalango-epiphyseal dysplasia | GDF5 | dominant | |||
Alström syndrome | ALMS1 | 1:8,600,000 | |||
Alzheimer's disease | PSEN1, PSEN2, APP, APOEε4 | 1:177 | |||
Amelogenesis imperfecta | 1:14,000 | ||||
Aminolevulinic acid dehydratase deficiency porphyria | ALAD | 1:780,000,000 | |||
Androgen insensitivity syndrome | 1:20,000-50,000 | ||||
Angelman syndrome | UBE3A | 1:12,000-20,000 | |||
Aphalangy-syndactyly-microcephaly syndrome | dominant | ||||
Apert syndrome | FGFR2 | 1:65,000-80,000 | |||
Arthrogryposis–renal dysfunction–cholestasis syndrome | VPS33B | 1:78,000,000 | |||
Ataxia telangiectasia | ATM | 1:40,000-1,000,000 | |||
Axenfeld syndrome | PITX2, FOXO1A, FOXC1, PAX6 | 1:200,000 | |||
Bainbridge–Ropers syndrome | ASXL3 | de novo | |||
Beare–Stevenson cutis gyrata syndrome | 10q26, FGFR2 | 1:390,000,000 | |||
Beckwith–Wiedemann syndrome | IGF-2, CDKN1C, H19, KCNQ1OT1 | 1:15,000 | |||
Benjamin syndrome | 1:20,000,000 | ||||
biotinidase deficiency | BTD | 1:110,000,000 | |||
Björnstad syndrome | BCS1L | 1:260,000,000 | |||
Blepharophimosis intellectual disability syndromes | |||||
Bloom syndrome | 15q26.1 | 1:480,000 | |||
Birt–Hogg–Dubé syndrome | 17 FLCN | 1:19,500,000 | |||
Brody myopathy | ATP2A1 | 1:10,000,000 | |||
Brunner syndrome | MAOA | 1:500,000,000 | |||
CADASIL syndrome | NOTCH3 | P | 1:156,000,000 | ||
Cat eye syndrome | 22 | 1:74,000 | |||
CRASIL syndrome | HTRA1 | 1:156,000,000 | |||
Chronic granulomatous disorder | 1:200,000 | ||||
Campomelic dysplasia | X 17q24.3–q25.1 | C | 1:40,000-200,000 | ||
Camptodactyly-taurinuria syndrome | dominant | ||||
Canavan disease | ASPA | 1:6,400-13,500 | |||
Carpenter Syndrome | RAB23 | 1:1,000,000 | |||
CDKL5 deficiency disorder | CDKL5 | [8] | 1:40,000-60,000[8] | ||
Cerebral dysgenesis–neuropathy–ichthyosis–keratoderma syndrome (CEDNIK) | SNAP29 | <1:1,000,000[9] | |||
Cleft palate short stature vertebral anomalies syndrome | |||||
Combined malonic and methylmalonic aciduria (CMAMMA) | ACSF3 | recessive | [10][11] | 1:30,000[10] | |
Combined malonic and methylmalonic aciduria (CMAMMA) | MLYCD | recessive | |||
Congenital muscular dystrophy-infantile cataract-hypogonadism syndrome | recessive | ||||
Cystic fibrosis | CFTR (7q31.2) | D or S | [12] | 1:100,000 | |
Charcot–Marie–Tooth disease | PMP22, MFN2 | 1:2,500 | |||
CHARGE syndrome | CHD7 | 1:8,500-10,000 | |||
Chédiak–Higashi syndrome | LYST | recessive | 1:39,000,000 | ||
Chondrodysplasia, Grebe type | GDF5 | autosomal recessive | [13] | ||
Cleidocranial dysostosis | RUNX2 | 1:7,800 | |||
Cockayne syndrome | ERCC6, ERCC8 | 1:2,600-3,900 | |||
Coffin–Lowry syndrome | X RPS6KA3 | 1:40,000-50,000 | |||
Cohen syndrome | COH1 | 1:7,800,000 | |||
collagenopathy, types II and XI | COL11A1, COL11A2, COL2A1 | ||||
Congenital insensitivity to pain with anhidrosis (CIPA) | NTRK1 | ||||
Congenital Muscular Dystrophy | multiple | dominant or recessive | [14] | ||
Corneal dystrophy-perceptive deafness syndrome | SLC4A11 | autosomal recessive | [15] | ||
Cornelia de Lange syndrome (CDLS) | HDAC8, SMC1A, NIPBL, SMA3, RAD21 | 1:10,000-30,000 | |||
Cowden syndrome | PTEN | 1:200,000 | |||
CPO deficiency (coproporphyria) | CPOX | ||||
Cranio-lenticulo-sutural dysplasia | 14q13–q21 | ||||
Cri du chat | 5p15.2 | D | [16][17] | 1:37,000-50,000 | |
Crohn's disease | 16q12 | P | |||
Crouzon syndrome | FGFR2, FGFR3 | 1.6:100,000 | |||
Crouzonodermoskeletal syndrome (Crouzon syndrome with acanthosis nigricans) | FGFR3 | 1:1,000,000 | |||
Currarino syndrome | HLXB9 | dominant | 1:100,000 | ||
Darier's disease | ATP2A2 | 1:30,000-100,000 | |||
Dent's disease (Genetic hypercalciuria) | Xp11.22 CLCN5, OCRL | ||||
Denys–Drash syndrome | WT1 | ||||
De Grouchy syndrome | 18q | D | |||
Dolichonychia | |||||
Down Syndrome | 21 | C | 1:1,000-1,100 1:1,200 (U.S.) | ||
DiGeorge syndrome | 22q11.2 | D | 1:4,000 | ||
Distal hereditary motor neuropathies, multiple types | HSPB8, HSPB1, HSPB3, GARS, REEP1, IGHMBP2, SLC5A7, DCTN1, TRPV4, SIGMAR1 | ||||
Distal muscular dystrophy | Dysferlin, TIA1, GNE (gene), MYH7, Titin, MYOT, MATR3, unknown | Dominant or recessive | [18] | ||
Duchenne muscular dystrophy | Dystrophin | X-linked recessive | [19] | ||
Dravet syndrome | SCN1A, SCN2A | 1:20,000-40,000 | |||
Ectrodactyly-polydactyly syndrome | |||||
Edwards Syndrome | 18 | trisomy | 1:5,000 | ||
Ehlers–Danlos syndrome | COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, TNXB, ADAMTS2, PLOD1, B4GALT7, DSE | dominant | 1:5,000 | ||
Emanuel syndrome | 11, 22 | partial trisomy | |||
Emery–Dreifuss syndrome | EMD, LMNA, SYNE1, SYNE2, FHL1, TMEM43 | ||||
Epidermolysis bullosa | KRT5, KRT14, DSP, PKP1, JUP, PLEC1, DST, EXPH5, TGM5, LAMA3, LAMB3, LAMC2, COL17A1, ITGA6, ITGA4, ITGA3, COL7A1, FERMT1 | dominant or recessive | [20][21] | 11.08:1,000,000 | |
Erythropoietic protoporphyria | FECH | 1:75,000-200,000 | |||
Fanconi anemia (FA) | FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ, FANCL, FANCM, FANCN, FANCP, FANCS, RAD51C, XPF | 1:130,000 | |||
Fabry disease | GLA (Xq22.1) | P | 1:117,000-476,000 | ||
Factor V Leiden thrombophilia | |||||
Fatal familial insomnia | PRNP | dominant | |||
Familial adenomatous polyposis | APC | 1:10,000-15,000 | |||
Familial dysautonomia | IKBKAP | ||||
Familial Creutzfeld–Jakob Disease | PRNP | dominant | |||
Familial episodic pain syndrome | TRPA1, SCN10A, SCN11A | dominant | |||
Familial thoracic aortic aneurysm and aortic dissection | FOXE3, SMAD2, LOX, MAT2A, ELN, HEY2, TGFB3, TGFBR1, TGFBR2, FBN1, ACTA2, MYLK, SMAD3, PRKG1, MFAP5, TGFB2, SMAD4, MYH11 | dominant | |||
Feingold syndrome | MYCN | ||||
FG syndrome | MED12 | ||||
FBXW7 neurodevelopmental syndrome | FBXW7 | ||||
Fibular aplasia-ectrodactyly syndrome | dominant | ||||
Fine-Lubinsky syndrome | MAF | recessive | |||
Fragile X syndrome | FMR1 | T | 1:4,000 males
1:8,000 females | ||
Friedreich's ataxia | FXN | T | 1:50,000 (U.S.) | ||
G6PD deficiency | |||||
Galactosemia | GALT, GALK1, GALE | ||||
Gaucher disease | GBA (1) | 1:20,000 | |||
Gerstmann–Sträussler–Scheinker syndrome | PRNP | dominant | |||
Gillespie syndrome | PAX6 | ||||
Glutaric aciduria, type I and type 2 | GCDH, ETFA, ETFB, ETFDH | recessive | |||
GRACILE syndrome | BCS1L | ||||
GRIN2B-related neurodevelopmental disorder | GRIN2B | ||||
Griscelli syndrome | MYO5A, RAB27A, MLPH | ||||
Gustavson syndrome | |||||
Hailey–Hailey disease | ATP2C1 (3) | ||||
Harlequin type ichthyosis | ABCA12 | ||||
Hemochromatosis type 1 | HFE (chromosome 6) | recessive | . | 1:200 (Northern Europe), 1:300 (Northern America) | |
Hemochromatosis type 2A | HJV (or HFE2A) (chromosome 1) | recessive | |||
Hemochromatosis type 2B | HAMP (or HFE2B) (chromosome 19) | recessive | |||
Haemochromatosis type 3 | TFR2 (or HFE3) (chromosome 7) | recessive | |||
Hemochromatosis type 4 | SLC40A1 (or HFE4) (chromosome 2) | dominant | |||
Hemochromatosis type 5 | FTH1 (chromosome 11) | dominant | |||
Hemophilia | FVIII | 1:7,500 males (hemophilia A)
1:40,000 males (hemophilia B) | |||
Hepatoerythropoietic porphyria | UROD | ||||
Hereditary coproporphyria | 3q12 | P | |||
Hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu syndrome) | ENG, ACVRL1, MADH4 | 1:5,000 [22] | |||
Hereditary inclusion body myopathy | GNE, MYHC2A, VCP, HNRPA2B1, HNRNPA1 | ||||
Hereditary multiple exostoses | EXT1, EXT2, EXT3 | 1:50,000 | |||
Hereditary spastic paraplegia (infantile-onset ascending hereditary spastic paralysis) | AP4M1, AP4S1, AP4B1, AP4E1 |
autosomal dominant, autosomal recessive or X-linked recessive |
2-6:100,000 | ||
Hermansky–Pudlak syndrome | HPS1, HPS3, HPS4, HPS5, HPS6, HPS7, AP3B1 | 1:500,000 | |||
Hereditary neuropathy with liability to pressure palsies (HNPP) | PMP22 | ||||
Heterotaxy | NODAL, NKX2-5, ZIC3, CCDC11, CFC1, SESN1 | ||||
Homocystinuria | CBS (gene) | recessive | [23] | ||
Huntington's disease | chromosome 4 HTT gene | autosomal dominant | 1:10,000 in USA | ||
Hunter syndrome | IDS | 1:100,000-150,000 males | |||
Hurler syndrome | IDUA | 1:100,000 | |||
Hutchinson–Gilford progeria syndrome | LMNA | 1:18,000,000 | |||
Hyperlysinemia | AASS | recessive | |||
Hyperoxaluria, primary | AGXT, GRHPR, DHDPSL | ||||
Hyperphenylalaninemia | 12q | ||||
Hypoalphalipoproteinemia (Tangier disease) | ABCA1 | ||||
Hypochondrogenesis | COL2A1 | ||||
Hypochondroplasia | FGFR3 (4p16.3) | ||||
Immunodeficiency–centromeric instability–facial anomalies syndrome (ICF syndrome) | 20q11.2 | ||||
Incontinentia pigmenti | IKBKG (Xq28) | P | |||
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly | MED17 | recessive | |||
Ischiopatellar dysplasia | TBX4 | dominant | |||
Isodicentric 15 | 15q11–14 | Inv dup | 1:30,000 [24] | ||
PRICKLE1-related progressive myoclonus epilepsy with ataxia | PRICKLE1 | dominant or recessive | |||
Jackson–Weiss syndrome | FGFR2 | ||||
Jacobsen syndrome | 11 | 1:100,000 | |||
Joubert syndrome | INPP5E, TMEM216, AHI1, NPHP1, CEP290, TMEM67, RPGRIP1L, ARL13B, CC2D2A, OFD1, TMEM138, TCTN3, ZNF423, AMRC9 | ||||
Juvenile-onset dystonia | ACTB, IMPDH2 | dominant | |||
Juvenile primary lateral sclerosis (JPLS) | ALS2 | ||||
Keloid disorder | |||||
KIF1A-Associated Neurological Disorder | KIF1A (2q37.3) | Dominant Negative | |||
Kleefstra syndrome | 9q34 | D | |||
Kniest dysplasia | COL2A1 | 1:1,000,000 | |||
Kosaki overgrowth syndrome | PDGFRB | ||||
Krabbe disease | GALC | 1:100,000 | |||
Kufor–Rakeb syndrome | ATP13A2 | ||||
LCAT deficiency | LCAT | ||||
Lesch–Nyhan syndrome | HPRT (X) | 1:380,000 | |||
Li–Fraumeni syndrome | TP53 | ||||
Limb-Girdle Muscular Dystrophy | Multiple | dominant or recessive | [25][26] | 1:14,500-123,000 | |
Lynch syndrome | MSH2, MLH1, MSH6, PMS2, PMS1, TGFBR2, MLH3 | 1:279 | |||
lipoprotein lipase deficiency | recessive | 1:1,000,000 | |||
Malignant hyperthermia | RYR1 (19q13.2) | dominant | 1:5,000-100,000 | ||
Maple syrup urine disease | BCKDHA, BCKDHB, DBT, DLD | recessive | |||
Marfan syndrome | 15 | dominant | 1:5,000-10,000 | ||
Maroteaux–Lamy syndrome | ARSB | recessive | 1:43,261-1,505,160 | ||
McCune–Albright syndrome | 20 q13.2–13.3 | 1:100,000-1,000,000 | |||
McLeod syndrome | XK (X) | 0.5-1:100,000 | |||
MEDNIK syndrome | AP1S1 | D | [27][28] | ||
Mediterranean fever, familial | MEFV | ||||
Menkes disease | ATP7A (Xq21.1) | 1:100,000-250,000 | |||
Methemoglobinemia | |||||
Methylmalonic acidemia | MMAA, MMAB, MMACHC, MMADHC, LMBRD1, MUT | recessive | 1:48,000 | ||
Micro syndrome | RAB3GAP (2q21.3) | ||||
Microcephaly | ASPM (1q31) | P | |||
Miller-Dieker syndrome | 17p13.3 | D | 1:100,000 | ||
Morquio syndrome | GALNS, GLB1 | 1:200,000-300,000 | |||
Mowat–Wilson syndrome | ZEB2 (2) | ||||
Muenke syndrome | FGFR3 | 1:30,000 | |||
Multiple endocrine neoplasia type 1 (Wermer's syndrome) | MEN1 | dominant | |||
Multiple endocrine neoplasia type 2 | RET | dominant | |||
Muscular dystrophy | multiple | AR, AD, X-linked | |||
Muscular dystrophy, Duchenne and Becker type | |||||
Myostatin-related muscle hypertrophy | MSTN | ||||
myotonic dystrophy | DMPK, CNBP | dominant or T | 1:8,000 | ||
Natowicz syndrome | HYAL1 | <1:1,000,000 | |||
NEDAMSS NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES | IRF2BPL(gene) | 14q24.3 | |||
Neurofibromatosis type I | 17q11.2 | ||||
Neurofibromatosis type II | NF2 (22q12.2) | ||||
Niemann–Pick disease | SMPD1, NPA, NPB, NPC1, NPC2 | 1:250,000 (types A and B)
1:150,000 (type C) | |||
Nonketotic hyperglycinemia | GLDC, AMT, GCSH | recessive | 1:60,000 | ||
Nonsyndromic deafness | |||||
Noonan syndrome | PTPN11, KRAS, SOS1, RAF1, NRAS, HRAS, BRAF, SHOC2, MAP2K1, MAP2K2, CBL | dominant | 1:1,000 | ||
Norman–Roberts syndrome | RELN | recessive | |||
Ogden syndrome | X | P | |||
Omenn syndrome | RAG1, RAG2 | recessive | |||
Osteogenesis imperfecta | COL1A1, COL1A2, IFITM5 | dominant | 1:15,000-20,000 | ||
Ostravik-Lindemann-Solberg syndrome | 2p15 | autosomal recessive | [29] | ||
Pantothenate kinase-associated neurodegeneration | PANK2 (20p13–p12.3) | recessive | 1-3:1,000,000 | ||
Patau syndrome (Trisomy 13) | 13 | trisomy | |||
PCC deficiency (propionic acidemia) | PC | recessive | 1:250,000 | ||
Porphyria cutanea tarda (PCT) | UROD | dominant | 1:10,000 | ||
Pendred syndrome | PDS (7) | recessive | |||
Peutz–Jeghers syndrome | STK11 | dominant | 1:25,000-300,000 | ||
Pfeiffer syndrome | FGFR1, FGFR2 | dominant | 1:100,000 | ||
Phelan-McDermid syndrome | 22q13 | D | |||
Phenylketonuria | PAH | recessive | 1:12,000 | ||
Pipecolic acidemia | AASDHPPT | recessive | |||
Pitt–Hopkins syndrome | TCF4 (18) | dominant, de novo | 1:11,000-41,000 | ||
Polycystic kidney disease | PKD1 (16) or PKD2 (4) | P | |||
Polycystic ovary syndrome (PCOS) | |||||
Porphyria | 1-100:50,000 | ||||
Prader–Willi syndrome | 15 | paternal imprinting | 1:10,000-30,000 | ||
Primary ciliary dyskinesia (PCD) | DNAI1, DNAH5, TXNDC3, DNAH11, DNAI2, KTU, RSPH4A, RSPH9, LRRC50 | recessive | 1:32,000 | ||
Primary pulmonary hypertension | |||||
Protein C deficiency | PROC | dominant | [30] | 1:20,000 | |
Protein S deficiency | PROS1 | dominant | |||
Proximal 18q deletion syndrome | 18q | D | |||
Pseudo-Gaucher disease | |||||
Pseudoxanthoma elasticum | ABCC6 | recessive | 1:25,000 | ||
Retinitis pigmentosa | RP1, RP2, RPGR, PRPH2, IMPDH1, PRPF31, CRB1, PRPF8, TULP1, CA4, HPRPF3, ABCA4, EYS, CERKL, FSCN2, TOPORS, SNRNP200, PRCD, NR2E3, MERTK, USH2A, PROM1, KLHL7, CNGB1, TTC8, ARL6, DHDDS, BEST1, LRAT, SPARA7, CRX | dominant or recessive | 1:4,000 | ||
Rett syndrome | MECP2 | dominant, often de novo | 1:8,500 females | ||
Roberts syndrome | ESCO2 | recessive | |||
Rubinstein–Taybi syndrome (RSTS) | CREBBP | dominant | 1:125,000-300,000 | ||
Sandhoff disease | HEXB | recessive | |||
Sanfilippo syndrome | SGSH, NAGLU, HGSNAT, GNS | 1:70,000 | |||
Scheuermann's disease | 1q21-q22 or 7q22 | autosomal dominant | 1:45 | ||
Schwartz–Jampel syndrome | HSPG2 | recessive | |||
Sjogren-Larsson syndrome | ALDH3A2 | Autosomal-recessive | , , | ||
Skin fragility-woolly hair-palmoplantar keratoderma syndrome | DSP | ||||
Spondyloepiphyseal dysplasia congenita (SED) | COL2A1 | dominant | |||
Shprintzen–Goldberg syndrome | FBN1 | dominant | |||
Sickle cell anemia | 11p15 | P | |||
Siderius X-linked mental retardation syndrome | PHF8 | X-Linked Recessive | |||
Sideroblastic anemia | ABCB7, SLC25A38, GLRX5 | recessive | |||
Sly syndrome | GUSB | recessive | 1:250,000 | ||
Smith–Lemli–Opitz syndrome | DHCR7 | recessive | 1:20,000-60,000 | ||
Smith–Magenis syndrome | 17p11.2 | dominant | 1:15,000-25,000 | ||
Snyder–Robinson syndrome | Xp21.3-p22.12 | recessive | <1:1,000,000 | ||
Spinal muscular atrophy | 5q | 1:10,000 | |||
Spinocerebellar ataxia (types 1–29) | ATXN1, ATXN2, ATXN3, PLEKHG4, SPTBN2, CACNA1A, ATXN7, ATXN8OS, ATXN10, TTBK2, PPP2R2B, KCNC3, PRKCG, ITPR1, TBP, KCND3, FGF14 | dominant, recessive or T | |||
Split hand split foot-nystagmus syndrome | dominant | ||||
SSB syndrome (SADDAN) | FGFR3 | dominant | |||
Stargardt disease (macular degeneration) | ABCA4, CNGB3, ELOVL4, PROM1 | dominant or recessive | 1-1.28:10,000 | ||
Stickler syndrome (multiple forms) | COL11A1, COL11A2, COL2A1, COL9A1 | dominant or recessive | 1:7,500-9,000 (U.S.) | ||
Strudwick syndrome (spondyloepimetaphyseal dysplasia, Strudwick type) | COL2A1 | dominant | |||
Tay–Sachs disease | HEXA (15) | recessive | |||
Tetrahydrobiopterin deficiency | GCH1, PCBD1, PTS, QDPR, MTHFR, DHFR | recessive | |||
Thanatophoric dysplasia | FGFR3 | dominant | 1:60,000 | ||
Thickened earlobes-conductive deafness syndrome | |||||
Treacher Collins syndrome | 5q32–q33.1 (TCOF1, POLR1C, or POLR1D) | dominant | 1:50,000 | ||
Tuberous sclerosis complex (TSC) | TSC1, TSC2 | dominant | 7-12:100,000 | ||
Turner syndrome | X | monosomy | 1:2,000-2,500 live female births | ||
Usher syndrome | MYO7A, USH1C, CDH23, PCDH15, USH1G, USH2A, GPR98, DFNB31, CLRN1 | recessive | 3-6:100,000 (type I) | ||
Variegate porphyria | PPOX | dominant | |||
Viljoen-Kallis-Voges syndrome | recessive | ||||
von Hippel–Lindau disease | VHL | dominant | 1:36,000 | ||
von Willebrand disease | VWF | dominant | 1:10,000 | ||
Waardenburg syndrome | PAX3, MITF, WS2B, WS2C, SNAI2, EDNRB, EDN3, SOX10 | dominant | 1:42,000 | ||
Warkany syndrome 2 | 8 | trisomy | |||
Weissenbacher–Zweymüller syndrome | COL11A2 | recessive | |||
Weyer's ulnar ray/oligodactyly syndrome | recessive | ||||
Williams syndrome | 7q11.23 | dominant | 1:10,000 | ||
Wilson disease | ATP7B | recessive | 1:30,000 | ||
Woodhouse–Sakati syndrome | C2ORF37 (2q22.3–q35) | recessive | |||
Wolf–Hirschhorn syndrome | 4p16.3 | dominant, often de novo | 1:50,000 | ||
Xeroderma pigmentosum | 15 ERCC4 | recessive | |||
X-linked intellectual disability and macroorchidism (fragile X syndrome) | X | ||||
X-linked spinal-bulbar muscle atrophy (spinal and bulbar muscular atrophy) | X | ||||
Xp11.2 duplication syndrome | Xp11.2 | D | 1:1,000,000 | ||
X-linked severe combined immunodeficiency (X-SCID) | X | ||||
X-linked sideroblastic anemia (XLSA) | ALAS2 (X) | ||||
47,XXX (triple X syndrome) | X | C | 1:1,000 females | ||
XXXX syndrome (48, XXXX) | X | 1:50,000 females | |||
XXXXX syndrome (49,XXXXX) | X | 1:85,000-250,000 females | |||
XXXXY syndrome (49,XXXXY) | X | 1:85,000-100,000 males | |||
XYY syndrome (47,XYY) | Y | 1:1,000 male births | |||
XXYY syndrome (48,XXYY) | X, Y | 1:18,000-40,000 males | |||
XYYY syndrome (48,XYYY) | Y | ||||
XXXY syndrome (48,XXXY) | X | 1:50,000 males | |||
XYYYY syndrome (49,XYYYY) | Y | 1:1,000,000 males | |||
Zellweger syndrome | PEX1, PEX2, PEX3, PEX5, PEX6, PEX10, PEX12, PEX13, PEX14, PEX16, PEX19, PEX26 | recessive |
References
- "OMIM Entry - # 118220 - CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A; CMT1A".
- Rodan LH, Qi W, Ducker GS, Demirbas D, Laine R, Yang E, et al. (September 2018). "5,10-methenyltetrahydrofolate synthetase deficiency causes a neurometabolic disorder associated with microcephaly, epilepsy, and cerebral hypomyelination". Molecular Genetics and Metabolism. 125 (1–2): 118–126. doi:10.1016/j.ymgme.2018.06.006. PMC 6557438. PMID 30031689.
- Mitchel MW, Moreno-De-Luca D, Myers SM, Levy RV, Turner S, Ledbetter DH, Martin CL (1993). "17q12 Recurrent Deletion Syndrome". In Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, Amemiya A (eds.). GeneReviews®. Seattle (WA): University of Washington, Seattle. PMID 27929632. Retrieved 2021-02-16.
- Roehlen N, Hilger H, Stock F, Gläser B, Guhl J, Schmitt-Graeff A, et al. (October 2018). "17q12 Deletion Syndrome as a Rare Cause for Diabetes Mellitus Type MODY5". The Journal of Clinical Endocrinology and Metabolism. 103 (10): 3601–3610. doi:10.1210/jc.2018-00955. PMID 30032214.
- Wan S, Zheng Y, Dang Y, Song T, Chen B, Zhang J (2019-05-17). "Prenatal diagnosis of 17q12 microdeletion and microduplication syndrome in fetuses with congenital renal abnormalities". Molecular Cytogenetics. 12 (1): 19. doi:10.1186/s13039-019-0431-7. PMC 6525371. PMID 31131025.
- Ferry Jr RJ. "Allgrove (AAA) Syndrome". Medscape. Retrieved 15 June 2020.
- "Orphanet: Alagille syndrome". www.orpha.net. Retrieved 2019-04-16.
- "CDKL5 deficiency disorder". MedlinePlus. Retrieved 7 June 2021.
- "Orphanet: CEDNIK syndrome". Retrieved 8 May 2021.
- NIH Intramural Sequencing Center Group; Sloan, Jennifer L; Johnston, Jennifer J; Manoli, Irini; Chandler, Randy J; Krause, Caitlin; Carrillo-Carrasco, Nuria; Chandrasekaran, Suma D; Sysol, Justin R; O'Brien, Kevin; Hauser, Natalie S; Sapp, Julie C; Dorward, Heidi M; Huizing, Marjan; Barshop, Bruce A (2011). "Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria". Nature Genetics. 43 (9): 883–886. doi:10.1038/ng.908. ISSN 1061-4036. PMC 3163731. PMID 21841779.
- Alfares, A.; Nunez, L. D.; Al-Thihli, K.; Mitchell, J.; Melancon, S.; Anastasio, N.; Ha, K. C. H.; Majewski, J.; Rosenblatt, D. S.; Braverman, N. (2011). "Combined malonic and methylmalonic aciduria: exome sequencing reveals mutations in the ACSF3 gene in patients with a non-classic phenotype". Journal of Medical Genetics. 48 (9): 602–605. doi:10.1136/jmedgenet-2011-100230. ISSN 0022-2593. PMID 21785126. S2CID 19352176.
- "FBR Model for Genetic Tests|ACCE|Genetic Testing|Genomics|CDC". www.cdc.gov. Retrieved 2017-10-24.
- Langer LO, Cervenka J, Camargo M (March 1989). "A severe autosomal recessive acromesomelic dysplasia, the Hunter-Thompson type, and comparison with the Grebe type". Human Genetics. 81 (4): 323–8. doi:10.1007/BF00283684. PMID 2703235. S2CID 27942659.
- "Orphanet: Congenital muscular dystrophy". www.orpha.net. Retrieved 2019-04-16.
- "Corneal dystrophy and perceptive deafness - About the Disease - Genetic and Rare Diseases Information Center". rarediseases.info.nih.gov. Retrieved 2022-08-03.
- "History and Prevalence of Cri du Chat Syndrome". findresources. Retrieved 15 June 2020.
- "OMIM Entry - # 123450 - CRI-DU-CHAT SYNDROME".
- "Distal Myopathies - Types of Distal MD". Muscular Dystrophy Association. 2015-12-18. Retrieved 2019-04-16.
- "OMIM Entry - # 310200 - MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD". omim.org. Retrieved 2019-04-16.
- Uitto J, Has C, Vahidnezhad H, Youssefian L, Bruckner-Tuderman L (January 2017). "Molecular pathology of the basement membrane zone in heritable blistering diseases:: The paradigm of epidermolysis bullosa". Matrix Biology. 57–58: 76–85. doi:10.1016/j.matbio.2016.07.009. PMID 27496350.
- Fine JD (November 2016). "Epidemiology of Inherited Epidermolysis Bullosa Based on Incidence and Prevalence Estimates From the National Epidermolysis Bullosa Registry". JAMA Dermatology. 152 (11): 1231–1238. doi:10.1001/jamadermatol.2016.2473. PMID 27463098.
- Faughnan ME, Mager JJ, Hetts SW, Palda VA, Lang-Robertson K, Buscarini E, et al. (December 2020). "Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia". Annals of Internal Medicine. 173 (12): 989–1001. doi:10.7326/M20-1443. PMID 32894695. S2CID 221542952.
- "OMIM Entry – # 236200 – Homocystinuria Due to Cystathionine Beta-Synthase Deficiency". omim.org. Retrieved 2018-03-01.
- Schinzel, Albert; Niedrist, Dunja (2001). "Chromosome imbalances associated with epilepsy". American Journal of Medical Genetics. 106 (2): 119–124. doi:10.1002/ajmg.1576. PMID 11579431.
- "Orphanet: Autosomal recessive limb girdle muscular dystrophy". www.orpha.net. Retrieved 2019-04-16.
- "Orphanet: Autosomal dominant limb girdle muscular dystrophy". www.orpha.net. Retrieved 2019-04-16.
- "'MEDNIK': A novel genetic syndrome". EurekAlert!. Retrieved 2017-10-24.
- "Hereditary disorder found in Que. families". CTV News. 4 December 2008. Archived from the original on 2008-12-07.
- "OMIM Entry - # 217085 - CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY; CHDTHP". omim.org. Retrieved 2022-05-11.
- "OMIM Entry – # 176860 – Thrombophilia Due to Protein C Deficiency, Autosomal Dominant; THPH3". omim.org. Retrieved 2018-03-01.
- "OMIM Entry - # 300263 - SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD". omim.org. Retrieved 2019-04-16.
- "OMIM Entry - # 300705 - CHROMOSOME Xp11.22 DUPLICATION SYNDROME". omim.org. Retrieved 2019-04-16.
Further reading
- "Specific Genetic Disorders". National Human Genome Research Institute (NHGRI). genome.gov. Retrieved 15 November 2017.
- "Congenital and Genetic Diseases | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. NIH.gov. Retrieved 15 November 2017.
- "Color Vision deficiency | Genetics Home Reference". ghr.nlm.nih.gov.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.